Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress toward oligonucleotide therapeutics: pharmacodynamic properties

S T Crooke1

  • 1Isis Pharmaceuticals, Carlsbad, California 92008.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|April 1, 1993
PubMed
Summary

Oligonucleotide therapeutics show promise, with the first drug candidate completing early clinical trials. Advances in medicinal chemistry are creating improved oligonucleotide drugs targeting nucleic acids.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human RNases H.

Methods in enzymology·2001
Same author

Preparation and use of ZFY-6 zinc finger ribonuclease.

Methods in enzymology·2001
Same author

The concept and application of antisense oligonucleotides.

Diseases of the colon and rectum·2001
Same author

Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration.

Biochemical pharmacology·2001
Same author

Potential roles of antisense technology in cancer chemotherapy.

Oncogene·2001
Same author

Investigating the structure of human RNase H1 by site-directed mutagenesis.

The Journal of biological chemistry·2001

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • Oligonucleotides are emerging as potential therapeutic agents.
  • The first therapeutic oligonucleotide (ISIS 2105) for genital warts is in clinical trials.
  • Understanding oligonucleotide interactions with biological targets is crucial for drug development.

Purpose of the Study:

  • To contextualize oligonucleotide therapeutics within modern drug discovery.
  • To review progress in the pharmacodynamics of oligonucleotides targeting nucleic acid receptors.

Main Methods:

  • Review of current scientific literature on oligonucleotide therapeutics.
  • Analysis of advances in medicinal chemistry for oligonucleotide drug design.
  • Focus on rational design principles for nucleic acid-binding oligonucleotides.

Related Experiment Videos

Main Results:

  • Oligonucleotide therapeutics demonstrate significant potential.
  • Rational design for nucleic acid interactions is well-understood, facilitating drug development.
  • New generations of oligonucleotide drugs with enhanced properties are emerging.

Conclusions:

  • Oligonucleotide therapeutics represent a promising area in drug discovery.
  • Continued advancements in medicinal chemistry are improving oligonucleotide drug characteristics.
  • Further research is needed to fully resolve remaining challenges in oligonucleotide therapy.